tiprankstipranks
BioMark Diagnostics (TSE:BUX)
:BUX

BioMark Diagnostics (BUX) Price & Analysis

Compare
3 Followers

BUX Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

55.87%44.13%
55.87% Insiders
Mutual Funds
― Other Institutional Investors
44.13% Public Companies and
Individual Investors

BUX FAQ

What was BioMark Diagnostics’s price range in the past 12 months?
BioMark Diagnostics lowest stock price was C$0.18 and its highest was C$0.32 in the past 12 months.
    What is BioMark Diagnostics’s market cap?
    BioMark Diagnostics’s market cap is C$24.54M.
      When is BioMark Diagnostics’s upcoming earnings report date?
      BioMark Diagnostics’s upcoming earnings report date is Jul 09, 2025 which is in 96 days.
        How were BioMark Diagnostics’s earnings last quarter?
        BioMark Diagnostics released its earnings results on Mar 01, 2025. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.004.
          Is BioMark Diagnostics overvalued?
          According to Wall Street analysts BioMark Diagnostics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does BioMark Diagnostics pay dividends?
            BioMark Diagnostics does not currently pay dividends.
            What is BioMark Diagnostics’s EPS estimate?
            BioMark Diagnostics’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does BioMark Diagnostics have?
            BioMark Diagnostics has 90,886,230 shares outstanding.
              What happened to BioMark Diagnostics’s price movement after its last earnings report?
              BioMark Diagnostics reported an EPS of -C$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of BioMark Diagnostics?
                Currently, no hedge funds are holding shares in TSE:BUX
                ---

                Company Description

                BioMark Diagnostics

                BioMark Diagnostics Inc., an oncology focused company, develops cancer diagnostic solutions to detect, monitor, and assess early treatment. It has a collaborative research agreement with the Icahn School of Medicine for clinical studies related to early lung cancer diagnosis. The company was incorporated in 2014 and is headquartered in Richmond, Canada. BioMark Diagnostics Inc. is a subsidiary of Biomark Technologies Inc.
                ---
                Similar Stocks
                Company
                Price & Change
                Follow
                Quarterhill
                Neo Performance Materials Inc
                Premier Health of America Inc
                Popular Stocks
                ---
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis